Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Awards

Esselen Award to Philip Low

by Alexandra A. Taylor
February 27, 2022 | A version of this story appeared in Volume 100, Issue 8

 

Philip S. Low, the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University, is being presented with the Gustavus John Esselen Award for Chemistry in the Public Interest for his use of chemistry to design and test promising therapies for multiple human diseases.

Low is being recognized for developing a widely applicable methodology for attaching drugs to molecules that will bind specifically to targeted disease sites. Low’s unique approach to treating malaria resulted in a recent breakthrough in treating the disease. Low will receive the award in a ceremony at Harvard University on April 29 and deliver a lecture titled “A New Generation of Targeted Therapies for Cancer, Autoimmune, and Infectious Diseases.”

The American Chemical Society Northeastern Section presents the award annually to honor outstanding scientific achievements that communicate the positive values of the chemical profession.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.